[Summary] A high-tech enterprise dedicated to the promotion, application, and in
Yantai Dongcheng Pharmaceutical Group Co., Ltd. (formerly Yantai Dongcheng Biochemical Co., Ltd.) was founded in 1998 and successfully listed on the Shenzhen Stock Exchange in May 2012. After nearly 20 years of accumulation and development, Dongcheng Pharmaceutical has grown into a large pharmaceutical enterprise group spanning four major fields: biochemical APIs, traditional Chinese medicines, chemical drugs, and nuclear medicine, integrating drug research and development, production, and sales. Since 2014, Dongcheng Pharmaceutical has entered the high-tech-barrier and high-growth nuclear medicine industry with a high starting point, successively acquiring Chengdu Yunke Pharmaceutical, Shanghai Yitai Pharmaceutical, and GMS (China), completing a full industrial chain layout from diagnostic nuclear drugs to therapeutic nuclear drugs. In 2017, Dongcheng Pharmaceutical reached a strategic equity cooperation with Nanjing Jiangyuan Andike, further consolidating its leading position in the field of nuclear medicine in China, becoming a provider capable of offering integrated solutions in nuclear medicine in the Chinese market. Nanjing Jiangyuan Andike Positron R&D Co., Ltd. has obtained the "Radioactive Drug Production License" and "Radioactive Drug Business License" issued by the National Medical Products Administration, obtained the FDG National Drug Approval Number, and passed the national GMP certification for pharmaceuticals. It is the second enterprise in China with complete professional qualifications for positron drug production and operation, and has been awarded the "High-tech Enterprise" certificate. The company is committed to building a nationwide networked production and supply system for positron radiopharmaceuticals, with PET drug distribution covering 17 provinces, municipalities, and autonomous regions nationwide. Currently, in regions such as East China, North China, Central China, Northwest, Southeast, Northeast, and Southwest, 15 "cyclotron PET drug production and distribution bases" have been built in accordance with GMP requirements, making the company the largest nuclear medicine product and comprehensive solution service provider in China.
What does Beijing Andike Electronics Co., Ltd. require? Who is Andike Medical hiring? Andike Medical recruitment: 工厂生产类占比最多占35.6%，其次是质量管理类占35.6%. What education can get in at Andike Medical? 本科占比最多占73.7%，其次是大专占25.4%. Work experience required at Andike Medical? 1-3年占比最多占53.4%，其次是3-5年占33.1%. Where are the job locations at Andike Medical? 南京占比最多占23.7%，其次是天津占10.2%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
